Women and epilepsy: review and practical recommendations

References

• National Institute for Health and Clinical Excellence (NICE). The Diagnosis and Management of Epilepsy in Adults and Children in Primary and Secondary Care. NICE. London, UK (2004).
   Google Scholar
• Taubøll E, Gjerstad L, Henriksen T, Husby H. Svangerskap og fødsel hos kvinner med epilepsi [Pregnancy and birth in women with epilepsy]. Tidsskr. Nor. Laegeforen.123, 1695–1697 (2003).
   PubMedGoogle Scholar
• Røste LS, Henriksen T, Gjerstad L, Husby H, Taubøll E et al. Retningslinjer for Behandling av Kvinner med Epilepsi. Konsensusrapport 2006. Den Norske Lægeforening, Norway. ISBN 978-82-8070-046-3, 1–36 (2007).
   Google Scholar
• Wheless JW, Kim HL. Adolescent seizures and epilepsy syndromes. Epilepsia43(Suppl. 3), 33–52 (2002).
   PubMedGoogle Scholar
• Stitt SL, Kinnard WJ. The effect of certain progestins and estrogens on the threshold of electrically induced seizure patterns. Neurology18, 213–216 (1968).
   PubMed Web of Science ®Google Scholar
• Herzog AG, Friedman MN. Menstrual cyclus interval and ovulation in women with localization-related epilepsy. Neurology57, 2133–2135 (2001).
   PubMed Web of Science ®Google Scholar
• Klein P, van Passel-Clark L, Pezzullo JC. Onset of epilepsy at the time of menarche. Neurology60, 495–497 (2003).
   PubMed Web of Science ®Google Scholar
• Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984. Epilepsia34, 453–468 (1993).
   PubMed Web of Science ®Google Scholar
• Svalheim S, Taubøll E, Bjørnenak T et al. Onset of epilepsy and menarche – is there any relationship? Seizure15, 571–575 (2006).
   PubMed Web of Science ®Google Scholar
• Herzog AG, Seibel MM, Schomer DL, Veitukaitis JL, Geschwind N. Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch. Neurol.43, 341–346 (1986).
   PubMed Web of Science ®Google Scholar
• Herzog AG, Coleman AE, Jacobs AR et al. Interictal EEG discharges, reproductive hormones, and menstrual disorders in epilepsy. Ann. Neurol.54, 625–637 (2003).
   PubMed Web of Science ®Google Scholar
• Bilo L, Meo R, Nappi C et al. Reproductive endocrine disorders in women with primary generalized epilepsy. Epilepsia29, 612–619 (1988).
   PubMed Web of Science ®Google Scholar
• Herzog AG, Friedman MN. Menstrual cycle interval and ovulation in women with localization-related epilepsy. Neurology57, 2133–2135 (2001).
   PubMed Web of Science ®Google Scholar
• Perucca E, Hedges A, Makki KA et al. A comparative study of the relative enzyme inducing properties of antiepileptic drugs in epileptic patients. Br. J. Clin. Pharmacol.18, 401–410 (1984).
   PubMed Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod.19, 41–47 (2004).
   PubMed Web of Science ®Google Scholar
• Isojärvi JIT, Laatikainen TJ, Pakarinen AJ, Juntunen KTS, Myllylä VV. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N. Engl. J. Med.329, 1383–1388 (1993).
   PubMed Web of Science ®Google Scholar
• Isojärvi JIT, Taubøll E, Pakarinen AJ et al. Altered ovarian function and cardiovascular risks in valproate treated women. Am. J. Med.111, 290–296 (2001).
   PubMed Web of Science ®Google Scholar
• O’Donovan C, Kusumakar V, Graves G, Bird D. Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder. J. Clin. Psychiatry64, 322–330 (2002).
   Google Scholar
• McIntyre RS, Mancini DA, McCann S, Srinivasan J, Kennedy SH. Valproate, bipolar disorder and polycystic ovarian syndrome. Bipolar Disord.5, 28–36 (2003).
   PubMed Web of Science ®Google Scholar
• Joffe H, Cohen LS, Suppes T et al. Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: a preliminary report. Biol. Psychiatry60(12), 1378–1381 (2006).
   PubMed Web of Science ®Google Scholar
• Røste LS, Taubøll E, Berner A, Isojärvi JIT, Gjerstad L. Valproate, but not lamotrigine, induced ovarian morphological changes in Wistar rats. Exp. Toxicol. Pathol.52, 545–552 (2001).
   PubMedGoogle Scholar
• Røste LS, Taubøll E, Isojärvi JIT, Pakarinen AJ, Huhtaniemi I, Gjerstad L. Effects of chronic valproate treatment on reproductive endocrine function in female and male Wistar rats. Reprod. Toxicol.16, 767–773 (2002).
   PubMed Web of Science ®Google Scholar
• Taubøll E, Gregoraszczuk EL, Kolodziej A, Kajta M, Ropstad E. Valproate inhibits conversion of testosterone to estradiol and acts as an apoptotic agent in growing porcine ovarian follicular cells. Epilepsia44, 1014–1021 (2003).
   PubMed Web of Science ®Google Scholar
• Rättyä J, Vainonpää L, Knip M, Lanning P, Isojärvi JIT. The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy. Pediatrics103, 588–593 (1999).
   PubMed Web of Science ®Google Scholar
• Vainionpää LK, Rättyä J, Knip M et al. Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Ann. Neurol.45, 444–450 (1999).
   PubMed Web of Science ®Google Scholar
• Isojarvi JI, Rättyä J, Myllylä VV et al. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann. Neurol.43, 446–451 (1998).
   PubMed Web of Science ®Google Scholar
• Bauer J, Jarre A, Klingmüller D, Elger CE. Polycystic ovary syndrome in patients with focal epilepsy: a study in 93 women. Epilepsy Res.41, 163–167 (2000).
   PubMed Web of Science ®Google Scholar
• Bilo L, Meo R, Valentino R, Di Carlo C, Striano S, Nappi C. Characterization of reproductive endocrine disorders in women with epilepsy. J. Clin. Endocrinol. Metab.86, 2950–2956 (2001).
   PubMed Web of Science ®Google Scholar
• Luef G, Abraham I, Trinka E et al. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women. J. Neurol.249, 835–841 (2002).
   PubMed Web of Science ®Google Scholar
• Luef G, Abraham I, Haslinger M et al. Hyperandrogenism, postprandial hyperinsulinism and the risk of PCOS in a cross sectional study of women with epilepsy treated with valproate. Epilepsy Res.73, 121–125 (2002).
   Google Scholar
• Betts T, Yarrow H, Dutton N, Greenhill L, Rolfe T. A study of anticonvulsant medication on ovarian function in a group of women with epilepsy who have only ever taken one anticonvulsant compared with a group of women without epilepsy. Seizure12(Suppl. 7), 323–329 (2003).
   PubMed Web of Science ®Google Scholar
• Taubøll E, Gregoraszczuk EL, Tworzydlo A, Wojtowicz K, Ropstad E. Comparison of reproductive effects of levetiracetam and valproate studied in prepubertal porcine ovarian follicular cells. Epilepsia 47(9), 1580–1583 (2006).
   PubMed Web of Science ®Google Scholar
• Svalheim S, Taubøll E, Dahl E et al. Levetiracetam affects gonadotropin levels and peripheral sex hormones in female Wistar rats. Epilepsia46(Suppl. 8), 189 (2005).
   PubMedGoogle Scholar
• Yerby MS. Special considerations for women with epilepsy. Pharmacotherapy20(8 Pt 2), 159–170 (2000).
   Google Scholar
• Schneider JG, Tompkins C, Blumenthal RS et al. The metabolic syndrome in women. Cardiol. Rev.14, 286–291 (2006).
   PubMedGoogle Scholar
• Taubøll E, Lundervold A, Gjerstad L. Temporal distribution of seizures in epilepsy. Epilepsy Res.8, 153–165 (1991).
   PubMed Web of Science ®Google Scholar
• Duncan S, Read CL, Brodie MJ. How common is catamenial epilepsy? Epilepsia34, 827–831 (1993).
   PubMed Web of Science ®Google Scholar
• Herzog AG, Harden CL, Liporace J et al. Frequency of catamenial seizure exacerbation in women with localisation-related epilepsy. Ann. Neurol.56, 431–444 (2004).
   PubMed Web of Science ®Google Scholar
• Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia38, 1082–1088 (1997).
   PubMed Web of Science ®Google Scholar
• Logothetis J, Harner R, Morrell F, Torres F. The role of estrogens in catamenial exacerbation of epilepsy. Neurology9, 352–360 (1959).
   PubMed Web of Science ®Google Scholar
• Herzog AG. Hormones and epilepsy. Acta Neurol. Scand.102(Suppl. 175), 29–31 (2000).
   Web of Science ®Google Scholar
• Feely M, Calvert R, Gibson J. Clobazam in catamenial epilepsy. A model for evaluating anticonvulsants. Lancet2(8289), 71–73 (1982).
   PubMed Web of Science ®Google Scholar
• Lim LL, Foldvary N, Mascha E, Lee J. Acetazolamide in women with catamenial epilepsy. Epilepsia42, 746–749 (2001).
   PubMed Web of Science ®Google Scholar
• Herzog AG. Clomiphene therapy in epileptic women with menstrual disorders. Neurology38, 432–434 (1988).
   PubMed Web of Science ®Google Scholar
• Trimble MR. On the use of tranquilisers in epilepsy. Epilepsia43(Suppl. 2), 25–27 (2002).
   PubMedGoogle Scholar
• Guberman A. Hormonal contraception and epilepsy. Neurology53(Suppl. 1), 38–40 (1999).
   PubMed Web of Science ®Google Scholar
• Crawford P, Chadwick DJ, Martin C et al. The interaction of phenytoin and carbaamzepine with combined contraceptive steroids. Br. J. Clin. Pharmacol.30, 892–896 (1990).
   PubMed Web of Science ®Google Scholar
• Saano V, Glue P, Banfeld CR et al. Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive. Clin. Pharmacol. Ther.58, 523–531 (1995).
   PubMed Web of Science ®Google Scholar
• Doose DR, Wang S-S, Padmanabhan M et al. Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and non-obese female subjects. Epilepsia44, 540–549 (2003).
   PubMed Web of Science ®Google Scholar
• Fattore C, Cipolla G, Gatti G et al. Induction of ethinyl estradiol and levonorgestrel metabolism by oxcarbazepine in healthy women. Epilepsia40, 783–787 (1999).
   PubMed Web of Science ®Google Scholar
• Sidhu J, Job S, Singh S et al. The pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. Br. J. Clin. Pharmacol.62, 191–199 (2005).
   Google Scholar
• Sabers A, Öhman I, Christensen J, Tomson T. Oral contraceptives reduce lamotrigine plasma levels. Neurology61, 570–571 (2003).
   PubMed Web of Science ®Google Scholar
• Reimers A, Helde G, Brodtkorb E. Ethinylestyradiol, but not gestagens reduces lamotrigine serum concentrations. Epilepsia46, 1414–1417 (2005).
   PubMed Web of Science ®Google Scholar
• Mattson RH, Cramer JA, Caldwell BV, Siconolfi BC. Treatment of seizures with medroxyprogesterone acetate: preliminary report. Neurology34, 1255–1258 (1984).
   PubMed Web of Science ®Google Scholar
• Crawford P. Best practice guidelines for the management of women with epilepsy. Epilepsia46(Suppl. 9), 117–124 (2005).
   PubMed Web of Science ®Google Scholar
• Tomson T, Perucca E, Battino D. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy. Epilepsia45, 1171–1175 (2004).
   PubMed Web of Science ®Google Scholar
• International League Against Epilepsy. Guidelines for the care of women of childbearing age with epilepsy. Commission on genetics, pregnancy, and the child. Epilepsia34, 588–589 (1993).
   PubMed Web of Science ®Google Scholar
• Nau H. Recommendations for the management and care of pregnant women with epilepsy. In: Epilepsy and Pregnancy. Tomson T, Gram L, Sillanpää M, Johannessen SI (Eds). Wrightson Biomedical Publishing, Petersfield, UK 201–208 (1997).
   Google Scholar
• Oquni M, Osawa M. Epilepsy and pregnancy. Epilepsia45(Suppl. 8), 37–41 (2004).
   PubMedGoogle Scholar
• Tettenborn B. Management of epilepsy in women of childbearing age. CNS Drugs20, 373–387 (2006).
   PubMed Web of Science ®Google Scholar
• Wallace H, Shorvon SD, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet352, 1970–1973 (1998).
   PubMed Web of Science ®Google Scholar
• Webber MP, Hauser WA, Ottman R, Annegers JF. Fertility in persons with epilepsy: 1935–1974. Epilepsia27, 746–752 (1986).
   PubMed Web of Science ®Google Scholar
• Artama M, Isojärvi JIT, Raitanen J, Auvinen A. Birth rate among patients with epilepsy: a nationwide population-based cohort study in Finland. Am. J. Epidemiol.159, 1057–1063 (2004).
   PubMed Web of Science ®Google Scholar
• Richmond JR, Krishnamoorthy P, Andermann E, Benjamin A. Epilepsy and pregnancy: an obstetric perspective. Am. J. Obstet. Gynecol.190, 371–379 (2004).
   PubMed Web of Science ®Google Scholar
• Yerby MS, Leppik I. Epilepsy and the outcome of pregnancy. J. Epilepsy3, 193–199 (1990).
   Google Scholar
• The EURAP Study Group. Seizure control and treatment in pregnancy: observations from the EURAP Epilepsy Pregnancy Registry. Neurology66, 354–360 (2006).
   PubMed Web of Science ®Google Scholar
• Teramo K, Hiilesmaa VK. Pregnancy and fetal complications in epileptic pregnancies. In: Epilepsy, Pregnancy, and the Child. Janz D, Dam M, Bossi L et al. (Eds). Raven Press, NY, USA 53–59 (1982).
   Google Scholar
• Tatum WO. The use of antiepileptic drugs in pregnancy. Exp. Rev. Neurother.6, 1077–1086 (2006).
   PubMedGoogle Scholar
• Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB. Antiepileptic drug pregnancy registry. Neurology64, 938–939 (2005).
   PubMed Web of Science ®Google Scholar
• Morrow J, Russell A, Guthrie E et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J. Neurol. Neurosurg. Psychiatr.77, 193–198 (2006).
   PubMed Web of Science ®Google Scholar
• Vajda FJ, Hitchcock A, Graham J et al. Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry Eur. J. Neurol.13, 645–654 (2006).
   PubMed Web of Science ®Google Scholar
• Pennell P. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology61(Suppl. 2), S35–S42 (2003).
   PubMed Web of Science ®Google Scholar
• Tran TA, Leppik IE, Blesi K, Sathanandan ST, Remmel R. Lamotrigine clearance during pregnancy. Neurology59, 251–255 (2002).
   PubMed Web of Science ®Google Scholar
• Ohman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia41, 709–713 (2000).
   PubMed Web of Science ®Google Scholar
• Mazzucchelli I, Onat FY, Ozkara C et al. Changes in disposition of oxcarbazepine and its metabolites during pregnancy and puerperium. Epilepsia47, 504–509 (2006).
   PubMed Web of Science ®Google Scholar
• Morrell MJ. Folic acid and epilepsy. Epilepsy Curr.2, 31–34 (2002).
   PubMedGoogle Scholar
• Kaaja E, Kaaja R, Matila R et al. Enzyme-inductive AEDs in pregnancy and the risk of bleeding in the neonate. Neurology58, 549–553 (2002).
   PubMed Web of Science ®Google Scholar
• Tsuboi T, Endo S. Incidence of seizures and EEG abnormalities among offspring of epileptic patients. Hum. Genet.36, 173–189 (1977).
   PubMed Web of Science ®Google Scholar
• Ottman R, Annegers JF, Hauser WA, Kurland LT. Higher risk of seizures in offspring of mothers than of fathers with epilepsy. Am. J. Hum. Genet.43, 257–264 (1988).
   PubMed Web of Science ®Google Scholar
• Scheffe IE, Berkovic SF. The genetics of human epilepsy. Trends Pharmacol. Sci.428–433 (2003).
   PubMed Web of Science ®Google Scholar
• Ohman I, Vitols S, Tomson T. Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy? Epilepsia46, 1621–1624 (2005).
   PubMed Web of Science ®Google Scholar
• Johannesen SI, Helde G, Brodtkorb E. Levetiracetam concentrations in serum and in breast milk at birth and during lactation. Epilepsia46, 775–777 (2005).
   PubMed Web of Science ®Google Scholar
• Lambert MV. Seizures, hormones and sexuality. Seizure10, 319–340 (2001).
   PubMed Web of Science ®Google Scholar
• Morrell MJ. Sexuality in epilepsy. In: A Comprehensive Textbook of Epilepsy. Engel J, Pedley T (Eds). Lippincott-Raven, PA, USA 2021–2026 (1997).
   Google Scholar
• Demerdash A, Shaalan M, Midani A, Kamel F, Bahri M. Sexual behavior of sample of females with epilepsy. Epilepsia32, 82–85 (1991).
   PubMed Web of Science ®Google Scholar
• Jensen P, Jensen SB, Sorensen PS et al. Sexual dysfunction in male and female patients with epilepsy: a study of 86 outpatients. Arch. Sex. Behav.19, 1–14 (1990).
   PubMed Web of Science ®Google Scholar
• Blumer D, Walker AE. Sexual behavior in temporal lobe epilepsy. Arch. Neurol.16, 37–43 (1967).
   PubMedGoogle Scholar
• Morrell MJ, Guldner G. Self reported sexual function and sexual arousability in women with epilepsy. Epilepsia37, 1204–1210 (1996).
   PubMed Web of Science ®Google Scholar
• Taylor DC. Sexual behavior and temporal lobe epilepsy. Arch. Neurol.21, 510–516 (1969).
   PubMed Web of Science ®Google Scholar
• Duncan S, Blacklaw J, Beastall GH, Brodie MJ. Sexual function in women with epilepsy. Epilepsia38, 1974–1981 (1997).
   Google Scholar
• Klein P, Serje A, Pezzullo JC. Premature ovarian failure in women with epilepsy. Epilepsia42, 1584–1589 (2001).
   PubMed Web of Science ®Google Scholar
• Harden CL, Nikolov BG, Koppel BS et al. Seizure frequency and age of menopause in women with epilepsy. Epilepsia42(Suppl. 7), 291 (2001).
   Google Scholar
• Lee MA. Epilepsy in the menopause. Neurology53(Suppl. 1), 41 (1999).
   Web of Science ®Google Scholar
• Harden CL, Pulver MC, Ravdin L, Jacobs AR. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia38(Suppl. 8), 133–134 (1997).
   Google Scholar
• Harden CL, Pulver MC, Ravdin L, Jacobs AR. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia40, 1402–1407 (1999).
   PubMed Web of Science ®Google Scholar
• Abbasi F, Krumholz A, Kittner SJ, Langenberg P. Effects of menopause on seizures in women with epilepsy. Epilepsia40, 205–210 (1999).
   PubMedGoogle Scholar
• Harden CL, Herzog AG, Nikolov BG et al. Hormone replacement therapy in women with epilepsy: a randomized double-blind, placebo-controlled study. Epilepsia47, 1447–1451 (2006).
   PubMed Web of Science ®Google Scholar
• Pack AM, Morrell MJ. Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications. CNS Drugs15, 633–642 (2001).
   PubMed Web of Science ®Google Scholar
• Stephen LS, McLellan AR, Harrison JH. Bone density and antiepileptic drugs: a case-controlled study. Seizure339–342 (1998).
   Web of Science ®Google Scholar
• Cummings SR, Nevitt MC, Genant HK et al. Risk factors for hip fracture in white women. Study of osteoporotic fractures research group. N. Engl. J. Med.332, 767–773 (1995).
   PubMed Web of Science ®Google Scholar
• Ensrud KE, Walczak TS, Blackwell T et al. Antiepileptic drugs use increases rates of bone loss in older women: a prospective study. Neurology62, 2051–2057 (2004).
   PubMed Web of Science ®Google Scholar
• Kumandas S, Koklu E, Gumus H et al. Effect of carbamazepine and valproic acid on bone mineral density, IGF-I and IGFBP-3. J. Pediatr. Endocrinol. Metab.19, 529–534 (2006).
   PubMed Web of Science ®Google Scholar
• Pack AM, Morrell M. Epilepsy and bone health in adults. Epilepsy Behav.5(Suppl. 2), S24–S29 (2004).
   PubMed Web of Science ®Google Scholar